Hydroxychloroquine, chloroquine, and remdesivir are among the drugs commonly discussed as treatments for the new viral infection, coronavirus disease 2019 (COVID-19). Previously, I described different ...
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This was a multicenter, randomized, open-label, parallel group, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback